Grundinformationen
- Standard-SMILES
[C-]#[N+]C- InChIKey
ZRKSVHFXTRFQFL-UHFFFAOYSA-N- Summenformel
- C2H3N
- Durchschnittliche Molmasse
- 41,05 g/mol
- Monoisotopische Masse
- 41,0265491
Überblick
Isocyanomethane is an isocyanide.
Namen und Bezeichner
- Bevorzugter Name
- Methyl isocyanide
- IUPAC
- isocyanomethane
- Lokaler Name
- Isocyanmethan
- Englischer Name
- METHYL ISOCYANIDE
- Summenformel
- C2H3N
- Molmasse
- 41.05
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
593-75-9- PubChem CID
- 11646
- DTXSID
DTXSID3075040- ChEBI
CHEBI:44177- UNII
- B5B6DXM7GG
- EC Number
- 209-806-9
- Nikkaji
- J2.698K
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 0
- Polarare Oberfläche (TPSA)
- 4,4 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 1
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 3
- Formalladung
- 0
- Komplexität
- 29,3
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Schmelzpunkt
- -45 °C · -45°C
- Siedepunkt
- 81.65 °C · 81.65°C (estimate)
- Dichte
- 0.7424 · 0.7424
- Brechungsindex
- 1.3427 · 1.3427
- storage temp.
- Refrigerator, Under inert atmosphere
- Löslichkeit
- Chloroform (Soluble), Methanol (Slightly)
- Aggregatzustand
- Oil
- Farbe
- Light Orange to Orange
- Wasserlöslichkeit
- 91 g/L · 91g/L(15 ºC)
- Spezifische Wärmekapazität
- 1.29 J/ · Cp(gas): 1.29 J/(g·K), at 25℃
- EPA chemische Informationen
- Methyl isocyanide (593-75-9)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (95%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P319, P321, P330, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Toxikologische Informationen
Treatment
Antidotes to cyanide poisoning include hydroxocobalamin and sodium nitrite, which release the cyanide from the cytochrome system, and rhodanase, which is an enzyme occurring naturally in mammals that combines serum cyanide with thiosulfate, producing comparatively harmless thiocyanate. Oxygen therapy can also be administered. (L97)
Health Effects
Exposure to high levels of cyanide for a short time harms the brain and heart and can even cause coma, seizures, apnea, cardiac arrest and death. Chronic inhalation of cyanide causes breathing difficulties, chest pain, vomiting, blood changes, headaches, and enlargement of the thyroid gland. Skin contact with cyanide salts can irritate and produce sores. (L96, L97)
Toxicity Summary
Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). It complexes with the ferric iron atom in this enzyme. The binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. As a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. Tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. Cyanide is also known produce some of its toxic effects by binding to catalase, glutathione peroxidase, methemoglobin, hydroxocobalamin, phosphatase, tyrosinase, ascorbic acid oxidase, xanthine oxidase, succinic dehydrogenase, and Cu/Zn superoxide dismutase. Cyanide binds to the ferric ion of methemoglobin to form inactive cyanmethemoglobin. (L97)
Sicherheitsdaten
- ridadr
- UN2929
- hazard_class
- 6.1, 3
Chemie und Industrie
Pharmakologische Informationen
Metabolism/Metabolites
Cyanide is rapidly alsorbed through oral, inhalation, and dermal routes and distributed throughout the body. Cyanide is mainly metabolized into thiocyanate by either rhodanese or 3-mercaptopyruvate sulfur transferase. Cyanide metabolites are excreted in the urine. (L96)
Verwendung und Herstellung
Anwendungen
VerwendenIsocyanomethane can be used as porous embolization microspheres comprising drugs.
Anbieter9 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…